These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 17382166)
1. Diagnosis of ureteropelvic junction obstruction in children: role of endothelin-1 in voided urine. Taha MA; Shokeir AA; Osman HG; Abd el-Aziz Ael-A; Farahat SE Urology; 2007 Mar; 69(3):560-4; discussion 564-5. PubMed ID: 17382166 [TBL] [Abstract][Full Text] [Related]
2. Obstructed versus dilated nonobstructed kidneys in children with congenital ureteropelvic junction narrowing: role of urinary tubular enzymes. Taha MA; Shokeir AA; Osman HG; Abd El-Aziz Ael-A; Farahat SE J Urol; 2007 Aug; 178(2):640-6. PubMed ID: 17574624 [TBL] [Abstract][Full Text] [Related]
3. Pelvi-ureteric junction obstruction in children: the role of urinary transforming growth factor-beta and epidermal growth factor. Taha MA; Shokeir AA; Osman HG; Abd El-Aziz Ael-A; Farahat SE BJU Int; 2007 Apr; 99(4):899-903. PubMed ID: 17378848 [TBL] [Abstract][Full Text] [Related]
4. Urinary and serum carbohydrate antigen 19-9 as a biomarker in ureteropelvic junction obstruction in children. Kajbafzadeh AM; Elmi A; Talab SS; Emami H; Esfahani SA; Saeedi P J Urol; 2010 Jun; 183(6):2353-60. PubMed ID: 20400153 [TBL] [Abstract][Full Text] [Related]
5. Role of urinary tubular enzymes in evaluation of children with ureteropelvic junction narrowing under conservative management. Shokeir AA; Taha MA Urology; 2009 May; 73(5):1016-20. PubMed ID: 19394498 [TBL] [Abstract][Full Text] [Related]
6. Urine levels of transforming growth factor-beta 1 in children with ureteropelvic junction obstruction. Palmer LS; Maizels M; Kaplan WE; Firlit CF; Cheng EY Urology; 1997 Nov; 50(5):769-73. PubMed ID: 9372890 [TBL] [Abstract][Full Text] [Related]
7. Ureteropelvic junction obstruction in children with renal ectopy. Kramer SA; Kelalis PP J Urol (Paris); 1984; 90(5):331-6. PubMed ID: 6501910 [TBL] [Abstract][Full Text] [Related]
8. Prospective evaluation of health related quality of life for pediatric patients with ureteropelvic junction obstruction. Parekh AD; Thomas JC; Trusler L; Ankerst DP; Deshpande JK; Adams MC; Pope JC; Brock JW J Urol; 2008 Nov; 180(5):2171-5; discussion 2175-6. PubMed ID: 18804796 [TBL] [Abstract][Full Text] [Related]
9. Risk factors for recurrent ureteropelvic junction obstruction after open pyeloplasty in a large pediatric cohort. Braga LH; Lorenzo AJ; Bägli DJ; Keays M; Farhat WA; Khoury AE; Salle JL J Urol; 2008 Oct; 180(4 Suppl):1684-7; discussion 1687-8. PubMed ID: 18708226 [TBL] [Abstract][Full Text] [Related]
10. Vesicoureteral reflux and ureteropelvic junction obstruction in children with horseshoe kidney: treatment and outcome. Cascio S; Sweeney B; Granata C; Piaggio G; Jasonni V; Puri P J Urol; 2002 Jun; 167(6):2566-8. PubMed ID: 11992090 [TBL] [Abstract][Full Text] [Related]
11. Postnatal unilateral pelviureteral junction obstruction: impact of pyeloplasty and conservative management on renal function. Shokeir AA; El-Sherbiny MT; Gad HM; Dawaba M; Hafez AT; Taha MA; Saida M; Ghaly AM Urology; 2005 May; 65(5):980-5; discussion 985. PubMed ID: 15882736 [TBL] [Abstract][Full Text] [Related]
12. Predicting the clinical outcome of congenital unilateral ureteropelvic junction obstruction in newborn by urinary proteome analysis. Decramer S; Wittke S; Mischak H; Zürbig P; Walden M; Bouissou F; Bascands JL; Schanstra JP Nat Med; 2006 Apr; 12(4):398-400. PubMed ID: 16550189 [TBL] [Abstract][Full Text] [Related]
13. The roles of serum and urinary carbohydrate antigen 19-9 in the management of patients with antenatal hydronephrosis. Atar A; Oktar T; Kucukgergin C; Kalelioglu I; Seckin S; Ander H; Ziylan O; Kadioglu TC J Pediatr Urol; 2015 Jun; 11(3):133.e1-5. PubMed ID: 25824879 [TBL] [Abstract][Full Text] [Related]
14. Laparoscopic dismembered pyeloplasty for ureteropelvic junction obstruction in children. Kojima Y; Sasaki S; Mizuno K; Tozawa K; Hayashi Y; Kohri K Int J Urol; 2009 May; 16(5):472-6. PubMed ID: 19383038 [TBL] [Abstract][Full Text] [Related]
15. [Lower pole pedicle in a series of 84 pyelo-ureteral junction syndromes surgically treated in children]. Lopez C; A'ch S; Veyrac C; Morin D; Averous M Prog Urol; 2000 Sep; 10(4):638-43. PubMed ID: 11064915 [TBL] [Abstract][Full Text] [Related]
16. Laparoscopic pyeloplasty in children: Is the outcome different in children under 2 years of age? Vicentini FC; Dénes FT; Borges LL; Silva FA; Machado MG; Srougi M J Pediatr Urol; 2008 Oct; 4(5):348-51. PubMed ID: 18790418 [TBL] [Abstract][Full Text] [Related]
17. Surgical management of congenital ureteropelvic junction obstruction: a Pediatric Health Information System database study. Vemulakonda VM; Cowan CA; Lendvay TS; Joyner BD; Grady RW J Urol; 2008 Oct; 180(4 Suppl):1689-92; discussion 1692. PubMed ID: 18708209 [TBL] [Abstract][Full Text] [Related]
18. Retroperitoneoscopic vs open dismembered pyeloplasty for ureteropelvic junction obstruction in children. Valla JS; Breaud J; Griffin SJ; Sautot-Vial N; Beretta F; Guana R; Gelas T; Carpentier X; Leculee R; Steyaert H J Pediatr Urol; 2009 Oct; 5(5):368-73. PubMed ID: 19369118 [TBL] [Abstract][Full Text] [Related]
19. Which is better--retroperitoneoscopic or laparoscopic dismembered pyeloplasty in children? Canon SJ; Jayanthi VR; Lowe GJ J Urol; 2007 Oct; 178(4 Pt 2):1791-5; discussion 1795. PubMed ID: 17707427 [TBL] [Abstract][Full Text] [Related]
20. Smooth muscle cell apoptosis and defective neural development in congenital ureteropelvic junction obstruction. Kajbafzadeh AM; Payabvash S; Salmasi AH; Monajemzadeh M; Tavangar SM J Urol; 2006 Aug; 176(2):718-23; discussion 723. PubMed ID: 16813927 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]